The content on this site is intended for healthcare professionals only
Dr Trněný speaks with ecancer at EHA 23 about a prognostic index for follicular lymphoma patients based on the PRIMA study.
In the NiHiL project, high risk patients stratified by microglobulin levels were found to be more likely to experience aggressive disease even if they were late responders.
Oncologists' perspectives and practices on minimal residual disease testing in multiple myeloma
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
GIST tumours and soft tissue sarcomas
Genomic testing: Awareness and effective communication between healthcare professionals and patients
Advancing breast cancer treatment in Uganda by improving molecular testing
Somatic mutation profile of breast cancer in Uganda
Choosing Wisely in pathology
